Truist Financial
IMMU

Truist Financial’s Immunomedics Inc IMMU Stock Holding History

Truist Financial’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-65,251
Closed -$5.55M – 2680
2020
Q3 		$5.55M Sell
65,251
-46,100
-41% -$2.33M 0.01% 724
2020
Q2 		$3.95M Buy
111,351
+16,328
+17% +$477K 0.01% 779
2020
Q1 		$1.28M Buy
95,023
+19,486
+26% +$328K ﹤0.01% 1158
2019
Q4 		$1.6M Buy
+75,537
New +$1.33M ﹤0.01% 1231

Truist Financial's IMMU Position: Q4 2020 in Review

Truist Financial sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 65,251 shares — an estimated $5.55M sold.

Truist Financial first reported a position in IMMU in Q4 2019 and held it in 4 quarters. The position peaked at $5.55M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Truist Financial reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Truist Financial sold 65,251 Immunomedics Inc shares in Q4 2020, an estimated $5.55M.
  • Truist Financial first reported a position in Immunomedics Inc in Q4 2019 and held it in 4 quarters.
  • Truist Financial's Immunomedics Inc position peaked at $5.55M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Truist Financial's 13F filing for Q4 2020, filed 18 Feb 2021.